BE857220R - Nouveaux composes pharmaceutiquement actifs - Google Patents

Nouveaux composes pharmaceutiquement actifs

Info

Publication number
BE857220R
BE857220R BE179689A BE179689A BE857220R BE 857220 R BE857220 R BE 857220R BE 179689 A BE179689 A BE 179689A BE 179689 A BE179689 A BE 179689A BE 857220 R BE857220 R BE 857220R
Authority
BE
Belgium
Prior art keywords
active compounds
pharmaceutically active
new pharmaceutically
new
compounds
Prior art date
Application number
BE179689A
Other languages
English (en)
French (fr)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of BE857220R publication Critical patent/BE857220R/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE179689A 1976-07-28 1977-07-27 Nouveaux composes pharmaceutiquement actifs BE857220R (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139276 1976-07-28

Publications (1)

Publication Number Publication Date
BE857220R true BE857220R (fr) 1978-01-27

Family

ID=10322420

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179689A BE857220R (fr) 1976-07-28 1977-07-27 Nouveaux composes pharmaceutiquement actifs

Country Status (9)

Country Link
US (4) US4139624A (OSRAM)
JP (1) JPS5315383A (OSRAM)
AU (1) AU2730377A (OSRAM)
BE (1) BE857220R (OSRAM)
DE (1) DE2733951A1 (OSRAM)
FR (1) FR2359838A1 (OSRAM)
LU (1) LU77854A1 (OSRAM)
NL (1) NL7708377A (OSRAM)
ZA (1) ZA774220B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264614A (en) 1978-11-16 1981-04-28 Glaxo Group Limited Amine derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219553A (en) * 1976-07-28 1980-08-26 Smith Kline & French Laboratories Limited Alkoxy pyridyl substituted alkanes
JPH0610632B2 (ja) * 1985-05-10 1994-02-09 株式会社日立製作所 音響インテンシティワットメ−タ
JPS63120228A (ja) * 1986-11-10 1988-05-24 Yoshida Kogyo Kk <Ykk> 音の方向成分分離測定方法
JPH01196521A (ja) * 1988-02-01 1989-08-08 Hitachi Ltd 振動インテンシテイワットメータ
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
US4062967A (en) * 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264614A (en) 1978-11-16 1981-04-28 Glaxo Group Limited Amine derivatives

Also Published As

Publication number Publication date
NL7708377A (nl) 1978-01-31
FR2359838A1 (fr) 1978-02-24
US4282224A (en) 1981-08-04
US4269844A (en) 1981-05-26
US4374839A (en) 1983-02-22
ZA774220B (en) 1978-06-28
AU2730377A (en) 1979-02-15
DE2733951A1 (de) 1978-02-02
US4139624A (en) 1979-02-13
LU77854A1 (OSRAM) 1977-10-24
JPS5315383A (en) 1978-02-13

Similar Documents

Publication Publication Date Title
ZA776129B (en) Pharmaceutically active compounds
BE854458A (fr) Composes antihypertensifs
BE852223A (fr) Nouveaux aminoalcoylheterocycles
FI773941A7 (fi) Foerfarande foer framstaellning av frysta granulat
DK206576A (da) Farmakologisk aktive forbindelser
MA18631A1 (fr) Nouveaux composes azotes heterocycliques
FR2346346A1 (fr) Nouveaux amino-chromanols
SE7710762L (sv) Farmakologiskt aktiva foreningar
BE824923A (fr) Nouveaux composes pharmaceutiquement actifs
BE850941A (fr) Nouveaux composes polypeptidiques
BE841001A (fr) Nouveaux composes piperidino
DK408577A (da) Indgivelsessaet
BE857219R (fr) Nouveaux composes pharmaceutiquement actifs
BE857220R (fr) Nouveaux composes pharmaceutiquement actifs
BE850843A (fr) Composes indolinospiropyrannes
NO771884L (no) Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider
SE7610967L (sv) Mellanamidpektin
BE857218A (fr) Nouveaux composes pharmaceutiquement actifs
BE837950A (fr) Nouveaux composes polycliques psychotropes
BE861351A (fr) Composes alcanoylanilides et leur preparation
DK510977A (da) Hygiejnisk-kosmetisk praeparat
BE872492A (fr) Nouveaux composes diazoiques
FR2340937A1 (fr) Nouveaux composes anti-hypertensifs
BE852955A (fr) Nouveaux amino-chromanols
SE7705857L (sv) Farmaceutiskt aktiva foreningar